STOCK TITAN
  1. Home
  2. Sec-filings
  3. ISRG
  4. [Form 4] INTUITIVE SURGICAL INC Insider Trading Activity

Intuitive Surgical officer exercises options, reports $550 share sales

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Intuitive Surgical (ISRG) reported an insider transaction by its VP Corporate Controller. On 11/05/2025, the officer exercised non-qualified stock options for 1,908 shares at $76.9989 and 159 shares at $59.4622, then sold the same amounts at $550 per share pursuant to a Rule 10b5-1 trading plan. Following these transactions, direct beneficial ownership stood at 473 common shares. The options exercised were granted under the 2010 Incentive Award Plan, with vesting schedules as disclosed.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 4: option exercises and sales under 10b5-1.

The ISRG officer exercised non-qualified stock options at strike prices of $76.9989 and $59.4622 on 11/05/2025, and sold the resulting shares at $550 per share under a disclosed Rule 10b5-1 plan. Such paired exercise-and-sale activity is common to cover taxes or diversify holdings.

After these transactions, direct beneficial ownership is 473 common shares. The derivative positions tied to these specific options show zero remaining following the exercises. This is administrative in nature; actual impact depends on insider allocation choices and does not alter company fundamentals.

Insider Widman Fredrik
Role VP Corporate Controller
Sold 2,067 shs ($1.14M)
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) 159 $0.00 --
Exercise Non-Qualified Stock Option (right to buy) 1,908 $0.00 --
Exercise Common Stock 1,908 $76.9989 $147K
Sale Common Stock 1,908 $550.00 $1.05M
Exercise Common Stock 159 $59.4622 $9K
Sale Common Stock 159 $550.00 $87K
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 0 shares (Direct); Common Stock — 2,381 shares (Direct)
Footnotes (1)
  1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Widman Fredrik
(Last) (First) (Middle)
1020 KIFER ROAD
(Street)
SUNNYVALE CA 94086
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP Corporate Controller
3. Date of Earliest Transaction (Month/Day/Year)
11/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/05/2025 M(1) 1,908 A $76.9989 2,381 D
Common Stock 11/05/2025 S(1) 1,908 D $550 473 D
Common Stock 11/05/2025 M(1) 159 A $59.4622 632 D
Common Stock 11/05/2025 S(1) 159 D $550 473 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $59.4622 11/05/2025 M(1) 159 (2) 02/16/2026 Common Stock 159 $0.0 0 D
Non-Qualified Stock Option (right to buy) $76.9989 11/05/2025 M(1) 1,908 (3) 08/15/2026 Common Stock 1,908 $0.0 0 D
Explanation of Responses:
1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026.
2. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
3. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
By: Stephanie Lim-Ignacio For: Widman, Fredrik 11/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did ISRG insider report on Form 4?

An officer exercised non-qualified stock options and sold the resulting shares on 11/05/2025 under a Rule 10b5-1 trading plan.

How many ISRG shares were sold and at what price?

Sales reported were 1,908 shares and 159 shares at $550 per share.

What options were exercised by the ISRG officer?

Options for 1,908 shares at $76.9989 and 159 shares at $59.4622 were exercised.

What is the officer's direct ownership after the transactions (ISRG)?

Direct beneficial ownership is 473 ISRG common shares.

Was the ISRG transaction under a 10b5-1 plan?

Yes. The filing states it occurred under a Rule 10b5-1 trading plan expiring May 21, 2026.

What equity plan were the options granted under (ISRG)?

They were granted pursuant to the 2010 Incentive Award Plan with stated vesting schedules.